XML 17 R114.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Parent Company Financial Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Assets        
Cash and cash equivalents $ 127,816 $ 72,873    
Other assets 8,044 7,444    
Total assets 2,267,195 1,900,614    
Liabilities and Shareholders' Equity        
Subordinated debentures 35,890 13,403    
Shareholders' equity 205,860 173,916 $ 149,686 $ 109,872
Total liabilities and shareholders' equity 2,267,195 1,900,614    
Revenues        
Interest income 92,652 76,657 61,209  
Expenses        
Interest expense 25,383 16,505 10,333  
Income tax benefit 7,621 6,401 10,616  
Net income 27,858 22,289 13,045  
Operating activities        
Net income 27,858 22,289 13,045  
Adjustments to reconcile net income to cash provided by (used for) operating activities        
Compensation expense related to stock options and restricted stock grants 1,698 1,502 1,258  
(Increase) decrease in other assets (600) 325 (1,183)  
Net cash provided by operating activities 18,282 31,703 17,193  
Investing activities        
Net cash used for investing activities (275,583) (301,708) (239,015)  
Financing activities        
Issuance of common stock     (24,758)  
Net cash provided by financing activities 312,244 250,713 267,435  
Net increase (decrease) in cash and cash equivalents 54,943 (19,292) 45,613  
Cash and cash equivalents, beginning of year 72,873 92,165 46,552  
Cash and cash equivalents, end of year 127,816 72,873 92,165  
Parent Company [Member]        
Assets        
Cash and cash equivalents 7,753 5,389    
Investment in subsidiaries 234,310 181,919    
Other assets 6 19    
Total assets 242,069 187,327    
Liabilities and Shareholders' Equity        
Accounts payable and accrued expenses 319 8    
Subordinated debentures 35,890 13,403    
Shareholders' equity 205,860 173,916    
Total liabilities and shareholders' equity 242,069 187,327    
Revenues        
Interest income 13 9 11  
Total revenue 13 9 11  
Expenses        
Interest expense 929 592 514  
Other expenses 240 240 246  
Total expenses 1,169 832 760  
Income tax benefit 243 173 262  
Loss before equity in undistributed net income of subsidiaries (913) (650) (487)  
Equity in undistributed net income of subsidiaries 28,771 22,939 13,532  
Net income 27,858 22,289 13,045  
Operating activities        
Net income 27,858 22,289 13,045  
Adjustments to reconcile net income to cash provided by (used for) operating activities        
Equity in undistributed net income of subsidiaries (28,771) (22,939) (13,532)  
Compensation expense related to stock options and restricted stock grants 1,698 1,502 1,258  
(Increase) decrease in other assets 12 12 2,772  
Increase (decrease) in accounts payable and accrued expenses (202) 2 2  
Net cash provided by operating activities 595 866 3,545  
Investing activities        
Investment in subsidiaries, net (27,334)  
Net cash used for investing activities (27,334)  
Financing activities        
Issuance of common stock 24,758  
Proceeds from the exercise of stock options and warrants 1,769 900 705  
Net cash provided by financing activities 1,769 900 25,463  
Net increase (decrease) in cash and cash equivalents 2,364 1,766 1,674  
Cash and cash equivalents, beginning of year 5,389 3,623 1,949  
Cash and cash equivalents, end of year $ 7,753 $ 5,389 $ 3,623